# Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

> **NCT00897039** · — · UNKNOWN · sponsor: **Southeastern Gynecologic Oncology** · enrollment: 60 (estimated)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer

## Interventions

- **OTHER:** flow cytometry
- **OTHER:** immunohistochemistry staining method

## Key facts

- **NCT ID:** NCT00897039
- **Lead sponsor:** Southeastern Gynecologic Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897039, "Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00897039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*